AKT1 and cancer: They may disrupt several signalling pathways that contribute to tumour growth, including the phosphoinositide 3-kinase/protein kinase B (PI3K)/Akt and nuclear factor-kappa B (NF-κB) pathways, which are both essential for the survival and growth of cancer cells [84].